Allergy (Peanut) Clinical Trials

A listing of Allergy (Peanut) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 23 clinical trials
Featured trial
Research Study for People with Peanut Allergy

We are enrolling adolescents and adults for a clinical research study to evaluate an investigational medication for peanut allergy.

  • 03 Oct, 2022
  • 1 location
  • 21 Oct, 2022
  • 59 locations
The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy

The prevalence of food allergy in the western world is a growing health problem. The majority of reactions are caused due to oral exposure to the known food allergen. However, there are reports about allergic symptoms after exposure to the allergenic food by contact and/ or inhalation. Most of those …

Accepts healthy volunteers
  • 02 Nov, 2021
  • 2 locations
CNP-201 in Subjects With Peanut Allergy

This study is a Phase 1b/2a randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, and pharmacodynamics of multiple ascending doses (Escalation Phase) of CNP-201 with the goal of identifying a safe and tolerable dose level to be evaluated further in a larger number of subjects (Expansion Phase).

  • 07 Oct, 2022
  • 10 locations
Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT

Open label study with peanut oral immunotherapy (OIT). Peanut allergic children aged >1 and <4 years of age will be randomized 2:1 to: Peanut OIT with slow up-dosing (40-60 weeks) up to a maintenance dose of 286 mg daily oral peanut protein and Control group with peanut allergic children who …

  • 10 Sep, 2021
  • 1 location
Immune and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy (CAFETERIA)

supervised double-blind, placebo-controlled oral food challenge [DBPCFC]) will be associated with attaining even higher thresholds over time in children with high threshold peanut allergy compared to those

allergic response
allergy to peanuts
  • 09 Apr, 2022
  • 1 location
VE416 for Treatment of Food Allergy

This is a single-center, randomized, double-blind trial with four arms evaluating VE416 as pretreatment or concurrent treatment in comparison to low-dose peanut oral immunotherapy (PNOIT) alone.

skin pricking
food allergy
skin prick test
  • 23 Apr, 2022
Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy

The purpose of this research is to gather information on the safety and efficacy of using a prebiotic as an adjunctive therapy to peanut oral immunotherapy. The prebiotic is not an FDA approved drug or medication rather a fiber found at local grocery stores.

  • 13 Mar, 2022
  • 1 location
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy (ATARI)

in adolescents and adults with persistent severe peanut allergy. This is a proof-of-concept trial in which the primary outcome will be the suppression of the initial peanut specific IgE surge

  • 27 May, 2022
  • 1 location
High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

In this trial the investigators aim to assess the effectiveness and safety of oral immunotherapy with peanut protein in high and low dose (300mg versus 150mg) in children with peanuts allergy

  • 20 Apr, 2021
  • 1 location